We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Industry

Roche Acquires High-Precision Dissection Technology from AvanSci Bio

Roche Diagnostics of the Roche group has signed a definitive Asset Purchase Agreement with AvanSci Bio for all products associated with the high-performance microdissection of slide-mounted tissue sections for subsequent molecular analysis.  More...
15 Dec 2014

Ferring and Roche Collaborate on Personalized Infertility Treatment

Ferring Pharmaceuticals and Roche have announced a companion diagnostic collaboration to improve clinical management of infertility treatment by improved tailoring to a woman’s specific needs.  More...
14 Dec 2014

Roche Enters Additional Sectors with Acquisition of Ariosa

Healthcare biotech leader Roche has announced its acquisition of privately held Ariosa Diagnostics, a leading molecular diagnostics testing service provider of a highly targeted and accurate noninvasive prenatal testing service through their CLIA laboratory using cell-free DNA technology.  More...
09 Dec 2014

Physician Office Testing Found Responsive to Developing World Needs

The points of strongest demand in the global physician office laboratory sector have converged around testing related to lifestyle diseases, according to a new report from Kalorama Information.  More...
08 Dec 2014

Foundations Fund Fast-Track Development of Ebola Test

Cepheid, a leading molecular diagnostics company, has announced the award of a grant of up to USD 3.3 million co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation to quickly develop its “Xpert Ebola” test for use in regions worst hit by the epidemic. Cepheid expects to deliver a prototype in as little as eight weeks.   More...
07 Dec 2014

TESARO and Myriad Expand Collaboration with New CDx Pair

The new collaboration will utilize the Myriad Genetics companion diagnostic “myChoice HRD” test to identify tumors with a homologous recombination deficiency. More...
01 Dec 2014

Women’s Health Diagnostics Grows to USD 8 Billion Sector

Kalorama Information estimates the market for women’s healthcare diagnostics to be USD 8.4 billion, according to its latest report. The report says the female population can benefit from earlier disease detection and tests taking the form of imaging, surgical, and in vitro approaches.   More...
30 Nov 2014
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Neonatal Heel Incision Device
Tenderfoot


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.